Effectiveness and safety of probiotic preparations in clinical treatment of inflammatory bowel disease

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2018, Vol 72, Issue

Abstract

Inflammatory bowel disease (IBD) is characterized by an aggressive immune response to luminal antigens including those of commensal microbiota, which are essential for intestinal homeostasis and appear to play a role in tolerance and immunity. Its disturbances can result in intestinal dysbiosis and the development of disease. The precise role of luminal bacteria in the pathogenesis of IBD has yet to be elucidated; however, considerable evidence implicates changes to bacterial communities associated with the gut mucosa in the disease state. It is also well known that beneficial microbes can confer a functional health benefit to the host. We analysed the effectiveness of probiotics to relieve symptoms in patients suffering from IBD. Using the Medline database and manually searching articles, we reviewed clinical trials performed with probiotics and lactic acid bacteria as supportive or alternative IBD treatments. The article summarizes IBD microenvironment and the efficiency of probiotic preparations in attenuating the symptoms of Crohn’s disease, ulcerative colitis, and pouchitis. The safety of probiotic intake is also analyzed based on existing outcomes of clinical trials and case reports. Strong evidence exists that probiotics are effective as supportive therapy for IBD; however, only a few preparations have well documented efficiency and safety. Clinical studies demonstrated that probiotics were more effective in preventing recurrence of the disease symptoms than in the management of its active stage. Some products may increase the risk of complications in specific patient groups; therefore, the use of probiotics should be considered with caution in the case of severe active IBD, especially with disrupted mucosa.

Authors and Affiliations

Ewa Wasilewska, Barbara Wroblewska

Keywords

Related Articles

Cats and dogs as a reservoir for Staphylococcus aureus

For many years, Staphylococcus aureus MRSA was thought to happen only in humans. It has now become an increasingly urgent problem in veterinary medicine, with MRSA infections reported in pets as well as farm animals. The...

Rola zewnątrzkomórkowych pęcherzyków błonowych w interakcji pasożyt-żywiciel

Zewnątrzkomórkowe pęcherzyki błonowe (EVs, extracellular vesicles), początkowo uważane za elementy zniszczonych komórek, okazały się niezwykle istotnym sposobem przekazywania informacji między komórkami, bez ich bezpośre...

MT1 melatonin receptors and their role in the oncostatic action of melatonin

Melatonin, the main hormone produced by the pineal gland, strongly inhibits the growth of cancer cells [i]in vitro[/i] and [i]in vivo[/i]. Some publications indicate that the addition of melatonin to culture medium slows...

Efflux-mediated antimicrobial multidrug resistance

Multidrug resistance is a major problem in the treatment of infectious diseases caused by bacteria and fungi. One of the basic mechanisms of resistance is active efflux of distinct drugs from cells. Export of toxic com...

Download PDF file
  • EP ID EP271456
  • DOI 10.5604/01.3001.0011.6471
  • Views 143
  • Downloads 0

How To Cite

Ewa Wasilewska, Barbara Wroblewska (2018). Effectiveness and safety of probiotic preparations in clinical treatment of inflammatory bowel disease. Advances in Hygiene and Experimental Medicine, 72(), 159-174. https://europub.co.uk/articles/-A-271456